New biotech innovation centre to develop drug test systems  

2007.03.30
A new Danish consortium has established a biotech innovation centre to develop test systems which can reveal how new drugs and food supplements affect the immune system
A consortium, comprising a number of Danish companies and universities, has established a biotech innovation centre to develop test systems which can reveal how new drugs and food supplements affect the immune system. The Danish Council for Technology and Innovation is supporting the Center for Immunomics with DKK 16 m (USD 2.9 m), while the parties in the consortium are jointly investing DKK 27 m (USD 4.9 m).
 
Lars Mikkelgaard-Jensen, chairman of the Danish Council for Technology and Innovation, says: "Part of the knowledge which today is spread across various research environments and the corporate sector will now be centralised. The centre will also fulfil a great need for companies seeking knowledge about the effect of their product candidates on the immune system."
 
Simon Skjøde Jensen, head of the new centre says: "The industry needs to have access to test systems which can quickly help develop the most suitable products. Our method minimises the risk of companies and research scientists using time and resources on developing products which have poor or even negative effect on immunologically related diseases."
 
The consortium members of the Center for Immunomics are Action Pharma, Bioneer, DanDrit Biotech, Dansico, Ferrosan, MediMush, Copenhagen University and the University of Southern Denmark. The news was reported by professional journal Ingeniøren (The Engineer).

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×